AskBio's AB-1002 gene therapy demonstrates preliminary efficacy in treating congestive heart failure, with no serious adverse events reported in early clinical data.
AskBio's AB-1005, a gene therapy for Parkinson's disease, has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA, potentially expediting its development.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.